9 Approved MS Therapies You Should Know About

Click here to receive MS news via e-mail
news_14_Artboard 343 copy 205

1. AMPYRA (dalfampridine)

news_14_Artboard 343 copy 155

Dalfampridine, marketed under the name Ampyra by Acorda Therapeutics in the United States (also referred to as Fampyra in Europe), is an FDA-approved drug that is used to improve walking in patients with multiple sclerosis (MS). Owing to its chemical properties and its role in the regulation of potassium channels on cell membranes, it is also used as a research tool in therapeutics dealing with several unmet medical conditions, as well as a convulsant to test for anti-seizure agents.

Learn more about Ampyra (dalfampridine) here.

Click here to receive MS news via e-mail

One comment

  1. Jan-Michael Wildeman says:

    Imran or Azathioprine is approved in USA and UK and Canada for reducing immune system inflammatory effects in the brain. I have had good results taking the prescribed 50mg 3 times daily for 22 years for my Primary Progressive MS. I wonder why it is not listed on this site. Similarly Sativex Medical Marijuana spray at night to relive neuropathic pain and heat pain at night so a good deep sleep without any “high” has been approved for MS but is absent from this list. ?

Leave a Comment

Your email address will not be published. Required fields are marked *